How Singulair Side Effects Could Possibly Affect Your Mental Health

Singulair blister pack
Corbis via Getty Images / Getty Images

Singulair, Accolate, Zyflo, and Zyflo CR have modified their product labeling to include information about certain potential mental health side effects that have been noted in patients using these products. Events that patients and health care providers need to be aware of include:

  • Agitation
  • Aggression
  • Anxiousness
  • Dream abnormalities
  • Hallucinations
  • Depression
  • Insomnia
  • Irritability
  • Restlessness
  • Suicidal thinking and behavior
  • Suicide
  • Tremor

If you notice any of these side effects you need to make sure that you immediately talk with your prescribing doctor. The FDA has the following recommendations to patients and providers regarding Singulair side effects and side effects of other leukotriene modifiers:

  • Patients and healthcare professionals should be aware of the potential for neuropsychiatric events with these medications.
  • Patients should talk with their healthcare providers if these events occur.
  • Healthcare professionals should consider discontinuing these medications if patients develop neuropsychiatric symptoms.

The latest prescribing information for these products can be found on the FDA website.

Alternatives to Singulair

While not part of the current asthma guidelines, there is at least one alternative to Singulair if you experience side effects or do not want to take the medication. Interestingly it's not even a drug, but rather a medical food.

Medical foods are defined under the Orphan Drug Act and regulated by the U.S. Food and Drug Administration (FDA). Just as it sounds, medical food is a product whose purpose is to function as a medical treatment by ingesting it as you would other foods. Rather than just eating healthy, these foods are particularly formulated to improve a disease. Likewise, this is not just food that you can pick up in the grocery store. The FDA says you need to be under the care of a doctor and they need to be routinely following you just as you need to do with any other asthma medication.

In this case, Lunglaid is a medical food that is designed to decrease leukotriene levels. The target population for this medical food is children with poorly controlled asthma who do not want to or cannot tolerate Singulair.

In clinical trials, Lunglaid demonstrated improved quality of life as well as decreases in leukotriene levels. Leukotriene homeostasis led to less chest tightness, cough, shortness of breath, and wheezing. Patients taking Lunglaid were noted to enjoy chores, sports, social activities as well as experiencing improved sleep. Also, side effects were no more common in the active treatment group than they were in the placebo group. Very few asthma treatments, even the ones with very few side effects, have a similar result from that perspective.

Was this page helpful?
Article Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. FDA Pediatric Advisory Committee. FDA Briefing Document for the September 27, 2019 Joint Meeting of the Pediatric and Drug Safety and Risk Management Committees. FDA. Published September 27, 2019.

  2. Badri T. Montelukast. StatPearls [Internet]. Published October 9, 2019.

  3. Philip G, Hustad C, Noonan G, et al. Reports of suicidality in clinical trials of montelukast. J Allergy Clin Immunol. 2009;124(4):691-6.e6. doi:10.1016/j.jaci.2009.08.010

  4. Erdem SB, Nacaroglu HT, Unsal Karkiner CS, Gunay I, Can D. Side Effects of Leukotriene Receptor Antagonists in Asthmatic ChildrenIran J Pediatr. 2015;25(5):e3313. doi:10.5812/ijp.3313

  5. Haarman MG, van Hunsel F, de Vries TW. Adverse drug reactions of montelukast in children and adultsPharmacol Res Perspect. 2017;5(5):e00341. doi:10.1002/prp2.341

  6. Herder M. What Is the Purpose of the Orphan Drug Act?PLoS Med. 2017;14(1):e1002191. Published 2017 Jan 3. doi:10.1371/journal.pmed.1002191

  7. Ramalingum N, Mahomoodally MF. The therapeutic potential of medicinal foodsAdv Pharmacol Sci. 2014;2014:354264. doi:10.1155/2014/354264

  8. Guilleminault L, Williams EJ, Scott HA, Berthon BS, Jensen M, Wood LG. Diet and Asthma: Is It Time to Adapt Our Message?Nutrients. 2017;9(11):1227. Published 2017 Nov 8. doi:10.3390/nu9111227

  9. Jo-Watanabe A, Okuno T, Yokomizo T. The Role of Leukotrienes as Potential Therapeutic Targets in Allergic DisordersInt J Mol Sci. 2019;20(14):3580. Published 2019 Jul 22. doi:10.3390/ijms20143580

  10. Cukic V, Lovre V, Dragisic D. Sleep disorders in patients with bronchial asthmaMater Sociomed. 2011;23(4):235–237. doi:10.5455/msm.2011.23.235-237

Additional Reading